{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:16:43Z","timestamp":1776525403935,"version":"3.51.2"},"reference-count":34,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dept. of Biotechnology, Govt. of India"},{"name":"Rajiv Gandhi Centre for Biotechnology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Antihypertensive drugs are widely used for the treatment of hypertension, and the choice of drug and dosage is based on trial and error. The variability in drug response and adverse reactions leads to the poor adherence to treatment. Epigenetic modulation is one of the major mechanisms that may contribute to the variability in drug responses, and microRNAs (miRNAs) can serve as crucial epigenetic regulators and have also been reported to be associated with hypertension pathogenesis. The objective of this study is to investigate the regulatory effects of commonly used antihypertensive drugs on the endothelial miRNome in human aortic endothelial cells. We aim to integrate miRNA expression data with proteomic analyses to elucidate drug-induced molecular mechanisms relevant to hypertension treatment. Whole genome small RNA sequencing was performed, followed by whole proteome analysis using LC-MS\/MS comparing between control and treated samples. The treatments induced significant differential regulation of several miRNAs and proteins; among these, a few reflected reverse relationships with miRNA regulation and protein expression. Certain miRNAs and their corresponding target proteins seem to distinguish between good therapeutic outcomes and potential side effects. This study unravels the potential role of drug-induced miRNAs in inducing post-transcriptional modifications to cause the differential expression of certain proteins that may induce not only therapeutic effects or drug side effects but can also indicate the potential for drug-repurposing in other diseases.<\/jats:p>","DOI":"10.3390\/cells14171359","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T08:28:15Z","timestamp":1756715295000},"page":"1359","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacoepigenomic Impact of Antihypertensive Drugs on miRNome and Proteome and Its Potential Influence on Health and Side Effects"],"prefix":"10.3390","volume":"14","author":[{"given":"Samyukta","family":"Bhass","sequence":"first","affiliation":[{"name":"Human Molecular Genetics Lab, Neurobiology and Genetics Division, BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, India"},{"name":"BRIC-Regional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad 121001, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0842-0398","authenticated-orcid":false,"given":"Moinak","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Human Molecular Genetics Lab, Neurobiology and Genetics Division, BRIC-Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695014, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/HYPERTENSIONAHA.113.01063","article-title":"Hypertension: A harbinger of stroke and dementia","volume":"62","author":"Faraco","year":"2013","journal-title":"Hypertension"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.phrs.2017.11.003","article-title":"Hypertension and cardiovascular risk: General aspects","volume":"129","author":"Kjeldsen","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_3","unstructured":"Khalil, H., and Zeltser, R. (2025). Antihypertensive Medications. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/pgs.10.34","article-title":"Pharmacogenomics of antihypertensive drugs: Past, present and future","volume":"11","author":"Johnson","year":"2010","journal-title":"Pharmacogenomics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/HJH.0000000000000988","article-title":"Why in 2016 are patients with hypertension not 100% controlled? A call to action","volume":"34","author":"Redon","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"ref_7","first-page":"230","article-title":"The World Health Report 2002\u2014Reducing Risks, Promoting Healthy Life","volume":"16","author":"Guilbert","year":"2003","journal-title":"Educ. Health Chang. Learn. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40885-018-0104-6","article-title":"Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital","volume":"25","author":"Gebreyohannes","year":"2019","journal-title":"Clin. Hypertens."},{"key":"ref_9","first-page":"29","article-title":"The Incidence Side Effects of Antihypertensive Drugs in the Intensive Care Unit General Hospital Dr. M. Ddjamil Padang","volume":"9","author":"Nosa","year":"2024","journal-title":"Int. J. Pharm. Sci. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00228-009-0620-0","article-title":"Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants","volume":"65","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1097\/HJH.0000000000001456","article-title":"In-utero exposure to antihypertensive medication and neonatal and child health outcomes: A systematic review","volume":"35","author":"Fitton","year":"2017","journal-title":"J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.124.21728","article-title":"microRNA and Hypertension","volume":"82","author":"He","year":"2025","journal-title":"Hypertension"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"119069","DOI":"10.1016\/j.atherosclerosis.2024.119069","article-title":"Circulatory miRNAs in essential hypertension","volume":"401","author":"Kostiniuk","year":"2025","journal-title":"Atherosclerosis"},{"key":"ref_14","unstructured":"Bhass, S., and Banerjee, M. (Epigenomics, 2025). Pharmacoepigenomic impact of anti-hypertensive drugs on DNA methylation: A genomewide methylation study, Epigenomics, Submitted."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sticht, C., De La Torre, C., Parveen, A., and Gretz, N. (2018). miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206239"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mohan, N., and Banerjee, M. (2025). Integrated Pharmacoepigenomic Analysis Uncovers the Impact of Antiseizure Medications on Developmental Pathways and the Protective Effect of Folic Acid. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26167981"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tang, D., Chen, M., Huang, X., Zhang, G., Zeng, L., Zhang, G., Wu, S., and Wang, Y. (2023). SRplot: A free online platform for data visualization and graphing. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0294236"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"D1333","DOI":"10.1093\/nar\/gkad1005","article-title":"The Human Phenotype Ontology in 2024: Phenotypes around the world","volume":"52","author":"Talapova","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","article-title":"miRNet 2.0: Network-based visual analytics for miRNA functional analysis and systems biology","volume":"48","author":"Chang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1161\/CIRCULATIONAHA.120.048845","article-title":"ALDH1A3 Coordinates Metabolism with Gene Regulation in Pulmonary Arterial Hypertension","volume":"143","author":"Li","year":"2021","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF03349828","article-title":"Intracellular calcium and blood pressure: Comparison between primary hyperparathyroidism and essential hypertension","volume":"18","author":"Fardella","year":"1995","journal-title":"J. Endocrinol. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM198702263160904","article-title":"Effects of a Circulating Factor in Patients with Essential Hypertension on Intracellular Free Calcium in Normal Platelets","volume":"316","author":"Lindner","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_23","first-page":"564","article-title":"Cell calcium and arterial blood pressure","volume":"15","author":"Gonzalez","year":"1995","journal-title":"Semin. Nephrol."},{"key":"ref_24","unstructured":"(2025, July 04). TMEM33 Gene\u2014GeneCards|TMM33 Protein|TMM33 Antibody. Available online: https:\/\/www.genecards.org\/cgi-bin\/carddisp.pl?gene=TMEM33."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41467-019-10045-y","article-title":"TMEM33 regulates intracellular calcium homeostasis in renal tubular epithelial cells","volume":"10","author":"Arhatte","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41467-019-08590-7","article-title":"tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis","volume":"10","author":"Savage","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, H., Zhao, X., Li, Y., Zhang, S., Wang, Y., Wang, L., and Ma, W. (2022). High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.908807"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Lu, L.F., Zhang, C., Li, Z.C., Zhou, X.Y., Jiang, J.Y., Chen, D.D., Zhang, Y.A., Xiong, F., Zhou, F., and Li, S. (2021). A novel role of Zebrafish TMEM33 in negative regulation of interferon production by two distinct mechanisms. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009317"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hazukov\u00e1, R., Zad\u00e1k, Z., Pleskot, M., Zdr\u00e1hal, P., Pumprla, M., and T\u00e1borsk\u00fd, M. (2024). Oxidative DNA Damage and Arterial Hypertension in Light of Current ESC Guidelines. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252312557"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.celrep.2015.01.054","article-title":"Human C6orf211 Encodes Armt1, a Protein Carboxyl Methyltransferase that Targets PCNA and Is Linked to the DNA Damage Response","volume":"10","author":"Perry","year":"2015","journal-title":"Cell Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1083\/jcb.201802076","article-title":"N-cadherin signaling via Trio assembles adherens junctions to restrict endothelial permeability","volume":"218","author":"Kruse","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1291\/hypres.31.873","article-title":"Vascular Permeability, Blood Pressure, and Organ Damage in Primary Hypertension","volume":"31","author":"Viazzi","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.HYP.25.5.913","article-title":"Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle Cells","volume":"25","author":"Williams","year":"1995","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/CS20190913","article-title":"Double-stranded RNA and Toll-like receptor activation: A novel mechanism for blood pressure regulation","volume":"134","author":"Justina","year":"2020","journal-title":"Clin. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1359\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:36:42Z","timestamp":1760035002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/17\/1359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":34,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cells14171359"],"URL":"https:\/\/doi.org\/10.3390\/cells14171359","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]}}}